Overview
- 16 inspections across 15 sites are on record.
- 89 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-04.
At a glance
Inspections
16
Sites
15
Observations
89
Career since
Aug 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| CTK OTC Laboratories LLC | 4 May 2026 | Human Drugs | On file |
| Westwood Laboratories, LLC. | 26 Mar 2026 | Human Drugs | On file |
| K.C. Pharmaceuticals, Inc | 13 Feb 2026 | Human Drugs | On file |
| J.M. Huber Micropowders, Inc. | 11 Feb 2026 | Human Drugs | On file |
| International Medication Systems Ltd. | 19 Dec 2025 | Human Drugs | On file |
Sites inspected
CTK OTC Laboratories LLCCorona, United States1 insp.
Westwood Laboratories, LLC.Azusa, United States1 insp.
K.C. Pharmaceuticals, IncPomona, United States1 insp.
J.M. Huber Micropowders, Inc.La Mirada, United States1 insp.
International Medication Systems Ltd.South El Monte, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Darren S Brown4 shared
Navneet Kaur3 shared
Thuy Tram L Nguyen2 shared
Pearl C Ozuruigbo2 shared
Crystal Monroy2 shared
Claudia M Perez-Kasmarski2 shared
Devisree P Mattigiri1 shared
Tareq W Haddad1 shared
Nathan E Hellman1 shared
Luis P Torres1 shared
Full investigator report
Get the verbatim findings behind Ngozi G Offor's 89 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site